Home / Business Development and Marketing Platform for CDMOs
Visibility & PositioningCDMO Profiles: Create a structured, SEO-optimized profile to effectively present your technical capabilities, regulatory compliance and therapeutic focus to pharma and biotech decision-makers. Search Engine Visibility: MAI CDMO Network invests continuously in SEO and provides performance analytics so CDMOs are easily discoverable by companies actively looking for outsourcing partners. |
|
|
Client Prospecting & Network AccessCustom Prospecting Tools: Identify and prioritize opportunities through clinical trials and patent data enriched with suitability insights aligned with your capabilities. MAI CDMO Network: Access a curated network of registered pharmaceutical and biotech companies, with visibility on company size and the type of products they are looking to manufacture. |
Quality Leads & MatchmakingActive Projects: Receive direct access to outsourcing projects published by pharma and biotech companies actively looking for development or manufacturing partners. Scientific Matchmaking: Our team supports request made to us to ensure relevance, alignment and efficient initiation of discussions. |
|
| REGISTER YOUR COMPANY | |
2026-02-12
Beyond Capacity: How Smarter Science is Redefining Biologics Manufacturing
See more
2026-02-04
What truly matters when selecting a Contract Manufacturing Organization for clinical and commercial success
See more
2026-01-30
Regulatory expertise can be the difference between a smooth veterinary drug approval and costly delays.
See more
Adare Pharma is a global CDMO with sites in US and EU providing turnkey product development through commercial manufacturing expertise focused on oral dosage forms for the Pharmaceutical, Animal Health and OTC markets. Adare s proprietary technology platforms specialize in ODT s, taste masking and customized drug release.
Activity: FDF / DRUG PRODUCTS, SERVICES manufacturing
Uses: Human, Veterinary
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium, Large
Compliance: ISO, EMA (EU GMP), FDA (cGMP), Health Canada...
Markets: DIGEMID (Peru), COFEPRIS (Mexico), INVIMA...
Accueil Sites Osny. Acquired in 2011, the Osny site specializes in the development and production of highly active solid pharmaceutical forms (hormonal and allergens). This 4,000 m2 pharmaceutical plant located 36 km northwest of Paris employs around a hundred people.
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Human
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium
Compliance: EMA (EU GMP), FDA (cGMP), ANVISA (Brazil B-GMP),...
Markets: FDA (USA), EMA (EU), PMDA (Japan), MHRA (UK), NMPA...
Tubilux Pharma: registered office; manufacturing facility
Activity: FDF / DRUG PRODUCTS, SERVICES manufacturing
Uses: Commercial (Phase IV), Human, Veterinary
Services: N/A
Batch Size / Reactor: Medium, Large
Compliance: EMA (EU GMP), FDA (cGMP), TGA (Australia GMP),...
Markets: FDA (USA), EMA (EU), TGA (Australia), ANVISA...
Your cGMP-compliant CDMO for end-to-end services in the complex oral solids dosage forms field, based in Binzen Germany
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Human,...
Services: Development services, Manufacturing services,...
Batch Size / Reactor: Small, Medium, Large
Compliance: EMA (EU GMP), FDA (cGMP)
Markets: FDA (USA), EMA (EU)
Cell Therapy company with excess Cleanroom capacity
Activity: FDF / DRUG PRODUCTS, BIOLOGICS, SERVICES manufacturing
Uses: Investigational, Commercial (Phase IV), Human
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium
Compliance: EMA (EU GMP)
Markets: EMA (EU)
Fully integrated CDMO solutions for Blow-Fill-Seal (BFS), sterile multidose, non-sterile multi-dose, sachets, capsules and tablets.
Activity: FDF / DRUG PRODUCTS, PARTICLE ENGINEERING manufacturing
Uses: Commercial (Phase IV), Human
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium, Large
Compliance: ISO, EMA (EU GMP), FDA (cGMP)
Markets: FDA (USA), EMA (EU)
Ophtalmic and Otic - Solutions, suspensions, emulsions, ointments and gels - FDA Approved facility
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Human,...
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium, Large
Compliance: ISO, EMA (EU GMP), FDA (cGMP), World Health...
Markets: FDA (USA), EMA (EU)
Seda Pharmaceutical Development Services specialises in integrated Pharmaceutical Development and Clinical Pharmacology.
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Human
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium
Compliance: ECOVADIS, MHRA (UK GMP)
Markets: DIGEMID (Peru), COFEPRIS (Mexico), INVIMA...
MAI CDMO Network is designed to support the day-to-day needs of Business Development and Marketing teams within Contract Development and Manufacturing Organizations.
Instead of relying on disconnected tools, external databases or purely inbound lead generation, MAI CDMO Network brings together visibility, prospecting intelligence and active outsourcing demand in a single, structured environment.
Effective CDMO marketing starts with being visible to the right audience. MAI CDMO Network enhances the discoverability of registered CMOs and CDMOs through SEO-driven content and structured company profiles that clearly communicate technical capabilities, therapeutic focus and manufacturing scope.
This visibility is complemented by direct access to pharmaceutical and biotech companies actively exploring outsourcing options.
For many CDMOs, identifying new projects and clients remains a fragmented and time-consuming process. Business development teams often rely on personal networks, trade shows, cold outreach or incomplete market intelligence, with limited visibility on which pharmaceutical or biotech companies are actively outsourcing.
MAI CDMO Network addresses this challenge by centralizing both active demand and proactive discovery tools. CDMOs gain access to companies currently evaluating outsourcing partners, as well as structured insights that help anticipate future manufacturing needs.
This approach enables CDMOs to focus on relevant opportunities, reduce unqualified outreach and engage earlier in development programs where strategic partnerships are formed.
The MAI CDMO Network provides BD teams with visibility on registered pharma and biotech companies, including information on company size, development stage and product types under development.
This allows CDMOs and CMOs to move beyond reactive lead handling and adopt a more proactive, informed and targeted approach to client engagement.
MAI CDMO Network integrates curated clinical trial and patent data, categorized and enriched with suitability insights aligned with each CDMO’s capabilities. These tools support opportunity prioritization and automated monitoring, helping BD teams focus time and resources on the most relevant programs.
Through the Active Projects module, pharmaceutical and biotech companies publish concrete development and manufacturing needs. These requests represent real, ongoing outsourcing demand and are supported by MAI CDMO Network’s scientific team to ensure relevance and clarity.
This combination of platform intelligence and human qualification enables efficient project matchmaking and higher-quality discussions.
By consolidating multiple functions (visibility, network access, prospecting intelligence and project matchmaking) into a single platform, MAI CDMO Network supports a scalable and resource-efficient approach to CDMO and CMO business development and marketing.
This allows teams of any size to operate with greater focus, consistency and impact.
Registration on MAI CDMO Network provides access to the tools, network and active projects described above.
If you have any questions or suggestions, click here. We will be happy to assist you.
